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Abstract 
Undifferentiated spindle and giant cell carcinoma is an extremely rare malignant neoplasm 
arising in the extrahepatic bile duct. We herein present the case of a 67-year-old male who 
developed an undifferentiated spindle and giant cell carcinoma of the proximal bile duct. A 
nodular infiltrating tumor was located at the proximal bile duct, resulting in obstructive 
jaundice. Histologically, the tumor was composed of mainly spindle-shaped and giant cells 
and showed positive immunoreactivity for both cytokeratin and vimentin. Adjuvant 
chemotherapy was administered following extrahepatic bile duct resection, and he has been 
doing well for 16 months since the surgical treatment. The literature on this rare malignancy 
is also reviewed and discussed. 
 
Introduction 
Carcinosarcomas are rare malignant tumors composed of both carcinomatous and 
sarcomatous components intermingled with each other, and are divided into true and 
‘so-called’ entities. True carcinosarcomas exhibit apparent differentiation, such as 
osteoid, rhabdoid or chondroid differentiation. Conversely, tumors that present both 
carcinomatous and sarcomatous components and undergo transitions between the 
two types of cells are known as so-called carcinosarcomas [1]. These tumors have 
previously been reported under a wide variety of names. According to the World Health 
Organization classification of tumors of the gallbladder and extrahepatic bile ducts, the 
latter tumor is defined as an undifferentiated carcinoma, spindle and giant cell type [2]. 
Although the majority of neoplasms occurring in the biliary tract are adenocarcinomas, 
the reported incidence of undifferentiated carcinoma is 0.38% of all gallbladder and 
extrahepatic bile duct cancers [3]. Moreover, this type of carcinoma is much more  
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common in the gallbladder than in the bile duct. To the best of our knowledge, only 
9 cases of spindle and giant cell type undifferentiated carcinoma arising in the 
extrahepatic bile duct have been reported in the English language literature [4–12]. 
We herein describe a further case of undifferentiated spindle and giant cell 
carcinoma of the proximal bile duct with interesting features. A review of the literature 
on this entity is also presented. 
Case Report 
A 67-year-old male was admitted to our hospital with jaundice and general fatigue. He had 
noticed white stool and brown urine 1 week prior to admission. He had no past history of liver 
or biliary disease. His laboratory data on admission were as follows: white blood cells 7,100/μl, 
red blood cells 467 × 104/μl, platelets 28.9 × 104/μl, serum total bilirubin 14.0 mg/dl (normal  
0.2–1.0), serum direct bilirubin 10.3 mg/dl (normal <0.3), serum aspartate aminotransferase 
496 IU/l (normal 10–35), alanine aminotransferase 1,080 IU/l (normal 5–40), lactate dehydrogenase 
433 IU/l (normal 120–230), serum alkaline phosphatase 1,360 IU/l (normal 110–360), serum 
gamma-glutamyl transpeptidase 1,530 IU/l (normal 10–50), serum amylase 81 IU/l (normal  
40–160), serum carcinoembryonic antigen 2.3 ng/ml (normal 0–5), and serum carbohydrate 
antigen 19-9 709 U/ml (normal <37). Computed tomography showed an enhanced mass with an 
unclear edge at the proximal bile duct, facing the right hepatic artery (fig. 1). Magnetic resonance 
cholangiopancreatography revealed stenosis of the common hepatic duct and bilateral intrahepatic 
duct dilatation (fig. 2). After hospitalization, an endoscopic nasobiliary drainage tube was inserted 
to decrease the hyperbilirubinemia and for treatment of presumptive cholangitis. A cytological 
examination of the drained bile juice identified malignant cells (adenocarcinoma). Under the 
preoperative diagnosis of proximal bile duct cancer, a hepatectomy of segments 1 and 4a combined 
with extrahepatic bile duct resection was scheduled because a further extended hepatectomy was 
concluded to be impossible due to the insufficient volume of the predicted future remnant liver, even 
if right portal vein embolization could be applied to increase the remnant liver volume. 
The intraoperative findings showed a main tumor at the proximal bile duct, which adhered to the 
right hepatic artery too strongly to be ablated completely. Therefore, combined partial resection of 
the right hepatic artery was added to the resection of the extrahepatic bile duct for curative intent, 
and the distal remnant of the right hepatic artery was consequently anastomosed to the harvested 
right gastroepiploic artery in an end-to-end fashion. Since the intraoperative histological examination 
showed that the bile duct surgical margin was free from malignant cells, we judged that a caudate 
hepatic lobectomy was not required. However, a hepatectomy of segment 4a was executed to make 
the reconstruction of the biliary tract easier. No distant metastasis or apparent lymph node 
metastasis was observed during the operation. Finally, we performed an extrahepatic bile duct 
resection with regional lymph node dissection, partial resection of the right hepatic artery, and a 
hepatectomy of segment 4a. 
The resected specimen showed a nodular infiltrating type tumor, measuring 1.7 × 1.2 cm in 
diameter, at the proximal bile duct. Histopathologically, the tumor consisted of mainly spindle-shaped 
and giant cells, and moderately differentiated tubular adenocarcinoma cells were also recognized in 
some areas (fig. 3a, b). The tumor extended down into the subserosa with perineural invasion, but 
showed neither vascular invasion nor lymph node metastasis. Immunohistochemical study revealed 
that the tumor cells were positive for cytokeratin 7 and vimentin (fig. 3c, d). On the basis of the 
aforementioned findings, the tumor was diagnosed to be undifferentiated carcinoma of the spindle 
and giant cell type. 
The patient had a good postoperative course and was discharged on the 37th day after the 
operation. Adjuvant chemotherapy using gemcitabine was administered, and he has survived without 
recurrence for 16 months after the surgical treatment.  
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Discussion 
In the present case, the tumor consisted of mainly spindle-shaped and giant cells 
without any apparent differentiation, showed both epithelial and mesenchymal 
immunoreactivities, and was finally diagnosed to be spindle and giant cell type 
undifferentiated carcinoma of the proximal bile duct. Only 9 cases of this type of 
undifferentiated carcinoma arising in the extrahepatic bile duct have been published in 
the English language literature (table 1). 
The preoperative diagnosis of undifferentiated carcinoma of the extrahepatic biliary 
system is considered to be difficult because the exact diagnosis could not be reached 
before surgical intervention in the previously reported 9 cases as well as the present 
case. A polypoid or nodular configuration was shown in 9 of the 10 cases with 
undifferentiated carcinoma of the extrahepatic bile duct, including the present case. 
Therefore these tumors occluded the bile duct and caused obstructive jaundice in most 
of the cases, but these findings are not sufficient to differentiate between usual 
adenocarcinoma and undifferentiated carcinoma. Furthermore, there are no peculiar 
radiographic features reported so far associated with this neoplasm. If an exact 
preoperative diagnosis is requested to decide the treatment modality, a sufficient 
volume of biopsy specimen should be obtained. 
In the literature, the prognosis of patients with undifferentiated carcinoma is very 
poor. The reported one-year survival rate for patients with undifferentiated carcinoma 
of the gallbladder was 18% [13], and the mean survival time for patients with 
undifferentiated carcinoma of the pancreas was estimated to be only 5 months [14]. 
The outcome of patients with this type of carcinoma of the extrahepatic bile duct is 
still uncertain because of the limited number of reported cases. In the 7 previous 
reports including follow-up studies, 2 patients died of postoperative complications 
(liver failure [5] and pulmonary infarction [10]) and 1 patient died 10 months after 
the operation due to local recurrence [6]. Nevertheless 4 patients were recurrence-free 
for 7–60 months since the surgical treatment [4, 7, 8, 11]. The present patient has also 
been doing well for 16 months after the surgery. Hence, these outcomes seem to be 
better than those of the gallbladder and pancreas. The reason why patients with 
undifferentiated carcinoma of the extrahepatic bile duct have a relatively better 
prognosis may be due to the early appearance of jaundice, consequently such cases may 
be diagnosed at a resectable stage before further tumor progression. However, this 
does not necessarily mean that there is a better surgical outcome of undifferentiated 
carcinoma of the extrahepatic bile duct, because the durations of observation are not 
long enough in cases without disease relapse. 
On the other hand, the recurrence-free cases showed a lack of any nodal involvement 
and a lack of any venous or lymphatic permeation. In contrast, the case that developed 
local recurrence had venous and lymphatic infiltration as well as perineural invasion, in 
spite of the fact that there was no metastasis to the regional lymph nodes [6]. This 
demonstrates that these invasion-related factors might be prognostic factors for 
patients with undifferentiated carcinomas. In our case, adjuvant chemotherapy was 
administered due to the detection of perineural invasion, and thus the patient has 
survived without recurrence since the surgical treatment, although continuation of 
careful follow-up is necessary. The most suitable adjuvant chemotherapeutic regimen is 
still the subject of much debate even for bile duct cancer, and this is the first report  
Case Rep Gastroenterol 2012;6:33–39 
DOI: 10.1159/000336198 
Published online: 
January 16, 2012 
© 2012 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
 
36
suggesting the possibility that a curative resection combined with adjuvant 
chemotherapy may contribute to prolonging the survival rate for this type of 
malignancy. 
At present, there is no optimal therapy for undifferentiated carcinoma of the 
extrahepatic bile duct. A favorable prognosis can be expected with curative resection 
for the locally invasive cases of this type of carcinoma. However, surgical resection 
alone is not sufficient to produce a radical cure in cases with any nodal involvement or 
vessel invasion. Therefore, it is conceivable that multidisciplinary therapy, including 
chemotherapy and/or radiotherapy, might be indispensable for such cases. To 
approach the establishment of an optimal treatment for this type of carcinoma, a 
further accumulation of cases and discussions, as well as a better understanding of its 
biological features, is required. 
 
 
 
Table 1. The reported cases of undifferentiated carcinoma, spindle and giant cell type, of the 
extrahepatic bile duct 
No.  Year  Age  Sex  Symptoms  Tumor    Surgical 
procedure 
Outcome 
location  size (cm)  form   
01  1994  52  F  pain, abdominal fullness  distal  4.0  polypoid    PD  15 months, alive 
02  1995  62  M  pain, jaundice  hepatic hilus  3.5  nodular    ELHL  10 days, dead 
03  2000  81  M  jaundice  middle  9.2  nodular    PPPD  10 months, dead 
04  2002  78  M  general fatigue  distal  1.0  polypoid    PD  15 months, alive 
05  2003  71  M  pain, jaundice  distal  1.2  nodular infiltrating   PD  60 months, alive 
06  2004  78  M  pain, jaundice  distal  4.0  wall irregular    PD  ND 
07  2007  59  M  jaundice, abdominal fullness  hepatic hilus  4.0  nodular    RTH  11 days, dead 
08  2007  61  M  pain, jaundice  middle  4.8  polypoid    PPPD  7 months, alive 
09  2010  65  M  jaundice  middle  1.5  nodular    PD  ND 
10  present 
case 
67  M  jaundice  proximal  1.7  nodular infiltrating   BDR  16 months, alive 
BDR = Extrahepatic bile duct resection; ELHL = extended left hepatic lobectomy; ND = no description; PD = pancreaticoduodenectomy; 
PPPD = pylorus-preserving pacreaticoduodenectomy; RTH = right trisection hepatectomy. 
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Fig. 1. Computed tomography revealed an enhanced mass at the proximal bile duct. Arrows indicate 
the mass lesion. 
 
 
 
Fig. 2. Magnetic resonance cholangiopancreatography showed a stricture of the common hepatic duct 
(arrow) and dilatation of the bilateral intrahepatic ducts. 
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Fig. 3. The histopathological findings revealed that the tumor consisted of mainly spindle-shaped cells 
(a; H&E, ×200). Giant cells were also recognized in some areas (b; H&E, ×100). The tumor cells had 
positive immunoreactivity for cytokeratin 7 (c; ×200) and vimentin (d; ×100). 
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